Session Description:

The product theatre aims to provide further understanding of the effectiveness and safety of cariprazine, a novel D3-D2 partial dopamine agonist. While novel medications are the driving force of improved treatment and eventually better life for patients, there is in general a bit of fear of trying out new drugs. To alleviate these fears, professor Göran Hajak will provide some insight in how to use cariprazine in the clinic, explain the rationale behind the clinical decisions to prescribe cariprazine and bring a few cases to illustrate the process.